Sudden Cardiac Death in Famous Athletes, Lessons Learned, Heterogeneity in Expert Recommendations and Pitfalls of Contemporary Screening Strategies
Authors:
Open Access
- 31 December 2019
- journal article
- review article
- Published by Cardiofront, LLC in Journal of Atrial Fibrillation
- Vol. 12 (4) , 2193
Abstract
Sudden cardiac death (SCD) in competitive athletes, though relatively uncommon, invariably leads to controversy. Specific limitations of an extensive screening process include lack of robust evidence to support prevention of SCD, poor cost-effectiveness and uncertain downstream implications of a positive screening test. An emerging body of evidence points to enhanced neurologically intact survival to hospital discharge when automated external defibrillators (AEDs) are used in a timely manner following sudden cardiac arrest (SCA). A viable alternative to an expansive screening process could be a robust secondary prevention system comprising of improvements in AED availability, stringent enforcement of CPR training in athletes and trainers to provide timely and effective resuscitation to reduce death following SCA. This strategy could widen the window to diagnose and treat the underlying etiology and prevent recurrence of SCA while also offering financial feasibility. Restricting athletes from competitive sports is a difficult decision for physicians owing to a lack of well-defined cutoffs for acceptable and prohibitive risk from pathology predisposing to SCD, especially in the absence of a protective medico-legal framework. In this review, we highlight a few cases that generated intense scrutiny by the public, media and medical professionals about the efficacy, feasibility and pitfalls of the existing screening process to diagnose cardiovascular pathology predisposing to SCD. Furthermore, contrasting approaches to screening, diagnosis and downstream workup protocols between the European Society of Cardiology and the American Heart Association are analyzed.Keywords
This publication has 35 references indexed in Scilit:
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and MyocarditisCirculation, 2015
- Public Access Defibrillation: Great benefit and potential but infrequently usedResuscitation, 2015
- Association of Bystander and First-Responder Intervention With Survival After Out-of-Hospital Cardiac Arrest in North Carolina, 2010-2013JAMA, 2015
- Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association AthletesCirculation, 2015
- Impact of Onsite or Dispatched Automated External Defibrillator Use on Survival After Out-of-Hospital Cardiac ArrestCirculation, 2011
- Clinical Challenges of Genotype Positive (+)–Phenotype Negative (−) Family Members in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2011
- Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening ProgramJAMA, 2006
- Failure of Commercially Available Chest Wall Protectors to Prevent Sudden Cardiac Death Induced by Chest Wall Blows in an Experimental Model of Commotio CordisPediatrics, 2006
- Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities—general considerationsJACC, 2005
- Sudden Cardiac DeathCirculation, 1998